Juniper Pharma Services (JPS), a Nottingham, England-based contract development and Manufacturing Organisation (CDMO) specializing in the development of challenging small molecules, said it is “significantly” expanding its UK-based drug development and clinical trial manufacturing facilities. The extension, planned to be completed this summer, will provide four additional process development laboratories at Nottingham that the company said will improve output and efficiency of its development and clinical manufacturing operations.
Original Article: Juniper Pharma Services in Lab Expansion